Also, CD56 identified as a predisposing factor for extramedullary manifestation and granulocytic sarcoma which is almost always followed by bone marrow relapse and should be treated with aggressive reinduction chemotherapy and local irradiation (Byrd and Weiss, 1994). Here, NCAM1 is linked to granulocytic sarcoma.